191 related articles for article (PubMed ID: 29928168)
1. Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland.
Jutzi M; Mansouri Taleghani B; Rueesch M; Amsler L; Buser A
Transfus Med Hemother; 2018 May; 45(3):151-156. PubMed ID: 29928168
[TBL] [Abstract][Full Text] [Related]
2. Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems.
Benjamin RJ; Braschler T; Weingand T; Corash LM
Transfusion; 2017 Dec; 57(12):2946-2957. PubMed ID: 28840603
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.
Infanti L; Holbro A; Passweg J; Bolliger D; Tsakiris DA; Merki R; Plattner A; Tappe D; Irsch J; Lin JS; Corash L; Benjamin RJ; Buser A
Transfusion; 2019 Nov; 59(11):3350-3361. PubMed ID: 31574181
[TBL] [Abstract][Full Text] [Related]
4. Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up.
Walther-Wenke G; Schrezenmeier H; Deitenbeck R; Geis G; Burkhart J; Höchsmann B; Sireis W; Schmidt M; Seifried E; Gebauer W; Liebscher UM; Weinauer F; Müller TH
Ann Hematol; 2010 Jan; 89(1):83-91. PubMed ID: 19484239
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Transfusion-Transmitted Bacterial Infections according to German Hemovigilance Data (2011-2020).
Orru' S; Oberle D; Heiden M; Müller S; Krut O; Funk MB
Transfus Med Hemother; 2023 Apr; 50(2):144-153. PubMed ID: 37066059
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of annual national hemovigilance data to assess pathogen reduced platelet transfusion trends during conversion to routine universal clinical use and 7-day storage.
Pitman JP; Payrat JM; Park MS; Liu K; Corash L; Benjamin RJ
Transfusion; 2023 Apr; 63(4):711-723. PubMed ID: 36802055
[TBL] [Abstract][Full Text] [Related]
7. Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.
Osselaer JC; Doyen C; Defoin L; Debry C; Goffaux M; Messe N; Van Hooydonk M; Bosly A; Lin JS; Lin L; Corash L
Transfusion; 2009 Jul; 49(7):1412-22. PubMed ID: 19389022
[TBL] [Abstract][Full Text] [Related]
8. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
9. Bacterial contamination of platelets for transfusion: strategies for prevention.
Levy JH; Neal MD; Herman JH
Crit Care; 2018 Oct; 22(1):271. PubMed ID: 30367640
[TBL] [Abstract][Full Text] [Related]
10. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
11. Reduction in adverse transfusion reactions with increased use of washed platelet concentrates in Japan-A retrospective multicenter study.
Ikebe E; Matsuoka S; Tanaka A; Yonemura Y; Fujii Y; Ohsaka A; Okazaki H; Kitazawa J; Ohtani S; Nakayama T; Momose SY; Miwa I; Taira R; Toyota K; Kino S; Kato H; Hamaguchi I
Transfus Apher Sci; 2019 Apr; 58(2):162-168. PubMed ID: 30670326
[TBL] [Abstract][Full Text] [Related]
12. Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases.
Razjou F; Dabir Moghaddam A; Karimi G; Zadsar M
Iran J Pathol; 2017; 12(2):112-118. PubMed ID: 29515632
[TBL] [Abstract][Full Text] [Related]
13. Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan.
Satake M; Mitani T; Oikawa S; Nagumo H; Sugiura S; Tateyama H; Awakihara S; Mitsutomi Y; Muraoka M; Tadokoro K
Transfusion; 2009 Oct; 49(10):2152-7. PubMed ID: 19500321
[TBL] [Abstract][Full Text] [Related]
14. Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center.
Bonn J; Baltin CT; Osterkamp V; Scheid C; Holtick U; Irsch J; Kron F
Oncol Res Treat; 2023; 46(9):362-369. PubMed ID: 37482056
[TBL] [Abstract][Full Text] [Related]
15. Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions.
Kobayashi J; Yanagisawa R; Ono T; Tatsuzawa Y; Tokutake Y; Kubota N; Hidaka E; Sakashita K; Kojima S; Shimodaira S; Nakamura T
Vox Sang; 2018 Feb; 113(2):128-135. PubMed ID: 29067694
[TBL] [Abstract][Full Text] [Related]
16. Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre.
Amato M; Schennach H; Astl M; Chen CY; Lin JS; Benjamin RJ; Nussbaumer W
Vox Sang; 2017 Jan; 112(1):47-55. PubMed ID: 28001297
[TBL] [Abstract][Full Text] [Related]
17. Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008.
Lafeuillade B; Eb F; Ounnoughene N; Petermann R; Daurat G; Huyghe G; Vo Mai MP; Caldani C; Rebibo D; Weinbreck P
Transfusion; 2015 Mar; 55(3):636-46. PubMed ID: 25257344
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of pathogen inactivated platelet quality: An 8 year experience of routine use in Galicia, Spain.
Castrillo Fernández A; Lanteri MC; Arcas Otero C; Díaz Pereira A; Adelantado Pérez M
Transfus Apher Sci; 2019 Feb; 58(1):87-93. PubMed ID: 30579750
[TBL] [Abstract][Full Text] [Related]
19. Septic transfusion case caused by a platelet pool with visible clotting due to contamination with Staphylococcus aureus.
Loza-Correa M; Kou Y; Taha M; Kalab M; Ronholm J; Schlievert PM; Cahill MP; Skeate R; Cserti-Gazdewich C; Ramirez-Arcos S
Transfusion; 2017 May; 57(5):1299-1303. PubMed ID: 28205241
[TBL] [Abstract][Full Text] [Related]
20. The assessment of platelet function by thromboelastometry as a point-of-care test to guide Intercept-treated platelet support in hemato-oncological patients and hematopoietic stem cell transplantation recipients.
Leitner GC; Ho M; Tolios A; Hopfinger G; Rabitsch W; Wohlfarth P
Transfusion; 2020 Jul; 60(7):1391-1399. PubMed ID: 32319678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
